Evidence map›Paper›PMID 30034947›Full record

ArticleCurrent protocols in chemical biology2018

ALARM NMR for HTS triage and chemical probe validation.

Jayme L Dahlin, Matthew Cuellar, Gurpreet Singh, Kathryn M Nelson, Jessica Strasser, Todd Rappe, Youlin Xia, Gianluigi Veglia, Michael A Walters

Abstract read
In one paragraph

Article in Current protocols in chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Applications of Solution NMR in Drug Discovery.Molecules (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jayme L DahlinDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Matthew CuellarInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
Gurpreet SinghInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
Kathryn M NelsonInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
Jessica StrasserInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
Todd RappeDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Youlin XiaDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Gianluigi VegliaDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Michael A WaltersInstitute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.

Funding

Mapping Allosteric Cooperativity in Protein KinasesR01GM100310 · NIGMS · UNIVERSITY OF MINNESOTA · PI VEGLIA, GIANLUIGI · 2012 to 2019
$4.3M
NIGMS NIH HHS R01 GM100310
6 · The paper itself

Abstract

Nonspecific target engagement by test compounds and purported chemical probes is a significant source of assay interference and promiscuous bioactivity in high-throughput screening (HTS) and chemical biology. Most counter-screens for thiol-reactive compounds utilize mass spectrometry or fluorescence detection, and non-proteinaceous reporters like glutathione that may not always approximate the reactivity of protein side-chains. By contrast, a La assay to detect reactive molecules by nuclear magnetic resonance (ALARM NMR) is an industry-developed protein-based [

Indexed as

High-Throughput Screening AssaysNuclear Magnetic Resonance, BiomolecularHumansLeukocyte Common AntigensMolecular ProbesProteinsReproducibility of ResultsLeukocyte Common AntigensMolecular ProbesProteinsassay interferencebioassay promiscuitychemical biologychemical probesdrug discoveryhigh-throughput screeningNMRthiol reactivity

Identifiers

PMID30034947
PMCPMC6053072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.